Bio-Rad Laboratories Inc (NYSE:BIO) — Stock Price
Bio-Rad Laboratories Inc (NYSE:BIO) is currently trading at $354.54 USD, up 0.59% today. Over the past 52 weeks, shares have ranged between $241.71 and $354.54. This page tracks Bio-Rad Laboratories Inc's live share price on the NYSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Bio-Rad Laboratories Inc.
Bio-Rad Laboratories Inc (BIO) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Bio-Rad Laboratories Inc's daily closing share price and trading volume on the NYSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Bio-Rad Laboratories Inc Income Statement — Revenue, Profit & Earnings by Year
Bio-Rad Laboratories Inc's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $2.58 Billion | $2.57 Billion | $2.67 Billion | $2.80 Billion | $2.92 Billion |
| Cost of Revenue | $1.24 Billion | $1.19 Billion | $1.24 Billion | $1.23 Billion | $1.28 Billion |
| Gross Profit | $1.34 Billion | $1.38 Billion | $1.43 Billion | $1.57 Billion | $1.64 Billion |
| Research & Development | $256.90 Million | $295.90 Million | $247.43 Million | $256.89 Million | $260.64 Million |
| SG&A | $844.30 Million | $814.00 Million | $846.80 Million | $827.83 Million | $879.57 Million |
| Total Operating Expenses | $1.08 Billion | $1.11 Billion | $1.09 Billion | $1.08 Billion | $1.14 Billion |
| Operating Income | $270.50 Million | $269.00 Million | $337.80 Million | $482.62 Million | $500.34 Million |
| EBITDA | $475.90 Million | $-2.14 Billion | $-654.80 Million | $-4.49 Billion | $5.59 Billion |
| EBIT | $270.50 Million | $-2.29 Billion | $-800.70 Million | $-4.67 Billion | $5.45 Billion |
| Interest Expense | $49.00 Million | $48.90 Million | $49.44 Million | $38.11 Million | $1.55 Million |
| Income Before Tax | $995.50 Million | $-2.34 Billion | $-850.10 Million | $-4.70 Billion | $5.45 Billion |
| Income Tax Expense | $235.60 Million | $-498.30 Million | $-212.78 Million | $-1.08 Billion | $1.19 Billion |
| Net Income | $759.90 Million | $-1.84 Billion | $-637.32 Million | $-3.63 Billion | $4.25 Billion |
Bio-Rad Laboratories Inc Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Bio-Rad Laboratories Inc's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $10.58 Billion | $9.36 Billion | $12.30 Billion | $13.50 Billion | $17.80 Billion |
| Total Current Assets | $2.91 Billion | $3.03 Billion | $3.05 Billion | $3.16 Billion | $1.99 Billion |
| Cash & Equivalents | $529.80 Million | $488.10 Million | $403.81 Million | $434.21 Million | $470.78 Million |
| Short-term Investments | $1.01 Billion | $1.18 Billion | $1.20 Billion | $1.36 Billion | $399.13 Million |
| Net Receivables | $472.50 Million | $452.50 Million | $489.00 Million | $494.64 Million | $423.54 Million |
| Inventory | $740.70 Million | $760.00 Million | $780.50 Million | $719.32 Million | $572.24 Million |
| Property, Plant & Equipment | $709.90 Million | $688.60 Million | $723.74 Million | $498.61 Million | $695.75 Million |
| Goodwill | $579.80 Million | $410.50 Million | $413.60 Million | $406.50 Million | $347.30 Million |
| Total Liabilities | $3.12 Billion | $2.79 Billion | $3.56 Billion | $3.89 Billion | $4.11 Billion |
| Total Current Liabilities | $517.00 Million | $467.80 Million | $522.80 Million | $568.71 Million | $680.94 Million |
| Long-term Debt | $1.20 Billion | $1.20 Billion | $1.20 Billion | $1.20 Billion | $10.51 Million |
| Net Debt | $999.20 Million | $886.60 Million | $1.00 Billion | $953.88 Million | $-247.41 Million |
| Total Stockholder Equity | $7.45 Billion | $6.57 Billion | $8.74 Billion | $9.62 Billion | $13.69 Billion |
| Retained Earnings | $8.18 Billion | $7.42 Billion | $9.26 Billion | $9.90 Billion | $13.53 Billion |
Bio-Rad Laboratories Inc Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Bio-Rad Laboratories Inc generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $532.20 Million | $455.20 Million | $374.94 Million | $194.45 Million | $656.52 Million |
| Capital Expenditures | $157.60 Million | $189.00 Million | $156.68 Million | $114.16 Million | $120.80 Million |
| Free Cash Flow | $374.60 Million | $266.20 Million | $218.26 Million | $80.29 Million | $535.72 Million |
| Investing Cash Flow | $-189.70 Million | $-160.20 Million | $20.21 Million | $-1.21 Billion | $-784.44 Million |
| Financing Cash Flow | $-283.20 Million | $-218.80 Million | $-425.65 Million | $973.58 Million | $-55.43 Million |
| Dividends Paid | — | — | $100.10 Billion | $68.18 Billion | $35.28 Billion |
| Stock-Based Compensation | $58.00 Million | $62.30 Million | $61.30 Million | $60.90 Million | $51.20 Million |
| Depreciation | $205.40 Million | $151.60 Million | $145.90 Million | $137.30 Million | $133.80 Million |
| Change in Cash | $40.30 Million | $85.40 Million | $-30.18 Million | $-36.59 Million | $-195.98 Million |
Bio-Rad Laboratories Inc Earnings History — EPS Actual vs. Analyst Estimates
Track Bio-Rad Laboratories Inc's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 30, 2026 | 1.89 | 2.55 | -25.88% |
| Feb 12, 2026 | 2.51 | 2.71 | -7.38% |
| Oct 30, 2025 | 2.26 | 1.94 | +16.49% |
| Jul 31, 2025 | 2.61 | 1.75 | +49.14% |
| May 01, 2025 | 2.54 | 1.78 | +42.70% |
| Feb 13, 2025 | 2.90 | 2.88 | +0.69% |
| Oct 30, 2024 | 2.01 | 1.18 | +70.34% |
| Aug 01, 2024 | 3.11 | 2.01 | +54.73% |